In an effort to develop hardware-free pacemakers, we and others have engaged into the development of gene therapy-based biological pacemakers by means of ion channel overexpression. Here we report our progress with regard to adeno associated virus (AAV) vectors-mediated delivery of HCN2/SkM1 to generate long-term biological pacing. To study the long-term efficacy of biological pacing based on AAV-mediated gene transfer of HCN2/SkM1. We tested in vitro AAV-mediated overexpression of HCN2 and SkM1 on transduced neonatal rat ventricular myocytes (NRVMs). In vivo gene transfer was further validated after injecting 1E11 GC of AAV6-cTNT-HCN2 or AAV6-CMV-SkM1 into the left ventricle free wall of adult mice. Functional biological pacemaker studies were performed in pigs with radiofrequency ablation-induced complete AV block (CAVB). Four weeks after the ablation, we proceeded with three groups: non-injected, saline, and AAV6-HCN2/SkM1 (5E12 GC per vector). All animals were then observed for another four weeks to evaluate in vivo biological pacemaker performance. AAV6-HCN2 and AAV6-SkM1 showed both robust expression in vitro (NRVMs) and in vivo (mice) (Figure 1B and 1C). We thus proceeded with in vivo testing in CAVB pigs. Within the first two weeks of gene delivery, maximal beating rate increased in the HCN2/SkM1-transduced animals (Figure 2B) and mean heart rate modestly trended up after one week after injection, although this trend was not sustained (Figure 2A). This increase in beating rates was accompanied by an abrupt reduction of electronically paced beats in HCN2/SkM1 animals showing dependency on backup pacing of less than 50% - one week after of transgene delivery (Figure 2C). Finally, we evaluated corrected ventricular recovery times after overdrive suppression pacing which indicated enhanced intrinsic pacemaker activity in HCN2/SkM1-injected animals (Figure 2D). AAV-mediated gene transfer results in robust long-term overexpression of HCN2 and SKM1 in mouse myocardium. AAV-HCN2/SkM1 gene transfer in CAVB pigs resulted in transient biological pacemaker activity, potentially stemming from insufficient in vivo transduction and/or immunological interference.View Large Image Figure ViewerDownload Hi-res image Download (PPT)
Read full abstract